10-Q: Huntsman Reports Steep Q2 Losses Amid Restructuring and Weak Demand
Quarterly Report
Huntsman Corporation reported significant net losses and declining revenues across all segments for the second quarter and first half of 2025, driven by lower selling prices, reduced sales volumes, and substantial restructuring charges.
Summary
- Net loss attributable to Huntsman Corporation for the three months ended June 30, 2025, was $158 million, a significant decline from a net income of $22 million in the same period of 2024.
- For the six months ended June 30, 2025, the net loss attributable to Huntsman Corporation was $163 million, compared to a net loss of $15 million in the prior year period.
- Revenues decreased by 7% to $1,458 million for the three months ended June 30, 2025, and by 6% to $2,868 million for the six months ended June 30, 2025, primarily due to lower average selling prices and sales volumes across all segments.
- Gross profit fell by 25% to $182 million for the three months and 14% to $383 million for the six months ended June 30, 2025.
- Operating loss was $120 million for the three months and $78 million for the six months ended June 30, 2025, a substantial deterioration from prior year periods.
- Adjusted EBITDA decreased by 44% to $74 million for the three months and by 31% to $146 million for the six months ended June 30, 2025.
- Restructuring, impairment, and plant closing costs significantly increased to $124 million for the three months and $125 million for the six months ended June 30, 2025, compared to $4 million and $15 million respectively in 2024.
- The Performance Products segment incurred $88 million in net restructuring expense, including $77 million for asset impairment and $14 million for goodwill impairment, related to the closure of its European maleic anhydride manufacturing facility in Moers, Germany.
- The Polyurethanes segment recorded $38 million in net restructuring expense for the six months ended June 30, 2025, due to a program to reduce organizational structure costs and optimize its European business.
- A final liquidating distribution of approximately $41 million in cash was received from the SLIC joint venture in the first quarter of 2025.
- Huntsman received a final award of approximately $66 million, including $23.5 million in interest, from a litigation matter against Praxair/Linde, recognizing $33 million in income net of legal fees.
- Net cash provided by operating activities from continuing operations improved to $21 million for the six months ended June 30, 2025, from a use of cash of $8 million in the prior year period.
- Free cash flow from continuing operations improved to a use of cash of $52 million for the six months ended June 30, 2025, from a use of $100 million in the prior year period.
- Total debt increased to $2,035 million as of June 30, 2025, from $1,835 million as of December 31, 2024, primarily due to net borrowings on revolving loan facilities.
- The 2022 Revolving Credit Facility was amended on May 23, 2025, to increase the maximum permitted leverage ratio through December 31, 2026, and to limit restricted payments for share repurchases during this period.
- A new Huntsman Corporation 2025 Stock Incentive Plan was approved on April 30, 2025, reserving 4.65 million shares for issuance.
- No shares were repurchased under the $2 billion share repurchase program during the six months ended June 30, 2025, with $547 million remaining under authorization.
- Dividends of $0.25 per share were declared for both the first and second quarters of 2025.
Sentiment
Score: 2
Explanation: The company reported significant net losses, substantial declines in revenues, gross profit, operating income, and adjusted EBITDA across all segments. While cash from operations improved and capital expenditures decreased, the overall financial performance is severely negative, marked by increased debt and significant restructuring costs. The amendment to the credit facility to increase the leverage ratio further underscores financial challenges.
Positives
- Net cash provided by operating activities from continuing operations improved to $21 million for the six months ended June 30, 2025, from a use of cash of $8 million in the prior year period.
- Free cash flow from continuing operations improved to a use of cash of $52 million for the six months ended June 30, 2025, from a use of $100 million in the prior year period.
- Received a final award of approximately $66 million from the Praxair/Linde litigation, resulting in $33 million in recognized income net of legal fees.
- Selling, general and administrative expenses decreased by 9% for the three months and 7% for the six months ended June 30, 2025, due to restructuring programs and favorable foreign currency translation.
- Capital expenditures from continuing operations decreased to $73 million for the six months ended June 30, 2025, from $92 million in the prior year period.
- A final liquidating distribution of approximately $41 million in cash was received from the SLIC joint venture.
Negatives
- Huntsman Corporation reported a net loss of $158 million for the three months ended June 30, 2025, a significant decline from net income in the prior year.
- The net loss for the six months ended June 30, 2025, widened to $163 million from $15 million in the comparable 2024 period.
- Total revenues decreased by 7% for the three months and 6% for the six months ended June 30, 2025, primarily due to lower average selling prices and sales volumes across all segments.
- Gross profit declined by 25% for the three months and 14% for the six months ended June 30, 2025.
- Operating income shifted to a significant loss of $120 million for the three months and $78 million for the six months ended June 30, 2025.
- Adjusted EBITDA decreased substantially by 44% for the three months and 31% for the six months ended June 30, 2025.
- Restructuring, impairment, and plant closing costs increased dramatically to $124 million for the three months and $125 million for the six months ended June 30, 2025.
- The Polyurethanes segment experienced a 61% decrease in adjusted EBITDA for the three months and 39% for the six months, primarily due to lower average selling prices and lower equity earnings from its China joint venture.
- The Performance Products segment saw a 30% decrease in adjusted EBITDA for both the three and six months, mainly due to lower sales volumes and unfavorable inventory reductions.
- The Advanced Materials segment's adjusted EBITDA decreased by 13% for the three months and 15% for the six months, primarily due to lower average selling prices.
- Equity in loss of investment in unconsolidated affiliates shifted from income to a loss, primarily due to increased losses at the PO/MTBE joint venture in China.
- Total debt increased by $200 million to $2,035 million as of June 30, 2025.
- The 2022 Revolving Credit Facility was amended to increase the maximum permitted leverage ratio, suggesting a need for greater financial flexibility due to current performance.
- The amendment also limits Huntsman International's ability to make restricted payments to Huntsman Corporation for share repurchases.
Risks
- Fluctuations in foreign currency exchange rates can impact cash flows and earnings, as the company does not hedge all exposures.
- Changes in interest rates can affect borrowing costs due to the mix of fixed and floating interest rates in the debt portfolio.
- The amount of actual availability under Accounts Receivable Programs may be lower based on eligible receivables sold, changes in customer credit ratings, customer concentration levels, and characteristics of transferred receivables.
- Any material failure to meet applicable A/R Programs metrics could lead to an early termination event, prohibiting additional borrowings or requiring full repayment, and would constitute an event of default under the 2022 Revolving Credit Facility.
- Future costs for capital improvements and general compliance under environmental, health, and safety (EHS) laws are subject to evolving regulatory requirements and may vary significantly.
- Potential liabilities for environmental remediation may exceed accrued amounts, and the company is unable to estimate the amount or range of such potential excess.
- The company is subject to various legal proceedings, including environmental and products liability laws, which could have a material effect on financial condition, results of operations, or liquidity.
- The company's ability to realize deferred tax assets is limited by cumulative losses incurred over the applicable period, and changes in expected future income could affect their realization.
Future Outlook
The company expects to spend between approximately $180 million to $190 million on capital expenditures during 2025, funded by cash provided by operations. Additional contributions of approximately $19 million are expected for pension and other postretirement benefit plans during the remainder of 2025. Further restructuring expenses of approximately $24 million are expected through 2027 for the Polyurethanes segment and approximately $6 million through 2027 for the Advanced Materials segment. The recently enacted U.S. tax reform legislation (OBBBA) is not expected to have a material impact on consolidated financial statements.
Management Comments
- Management believes that segment adjusted EBITDA more accurately reflects what the chief operating decision maker uses to make decisions about resources to be allocated to the segments and assess their financial performance.
- Management believes adjusted EBITDA is useful to investors in assessing the businesses ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses operational profitability.
- Management believes free cash flow is an important indicator of liquidity, used to evaluate liquidity, strategic investments, stock buyback and dividend levels, and ability to incur and service debt.
- Management believes the adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items not indicative of operational profitability.
- Management concluded that disclosure controls and procedures were effective as of June 30, 2025.
- Management can only give reasonable assurance that internal controls over financial reporting will prevent or detect material misstatements on a timely basis.
Industry Context
The chemical industry is experiencing challenging market conditions, as evidenced by lower average selling prices and reduced sales volumes across Huntsman's segments. The decline in MDI average selling prices due to 'less favorable supply and demand dynamics' suggests an oversupply or weakened demand in the polyurethane market. Softer market conditions also impacted the Performance Products segment. The decrease in demand in 'construction-related markets' and 'coatings and aerospace markets' indicates broader economic slowdowns affecting key end-use industries for Huntsman's products.
Comparison to Industry Standards
- NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Stock Incentive Plan Approval | Stockholders approved the new Huntsman Corporation 2025 Stock Incentive Plan, reserving 4.65 million shares for issuance. The Prior Plans remain in effect for outstanding awards but no new awards. | 2025-04-30 | This plan provides a framework for future equity compensation, aligning employee incentives with company performance, but also indicates potential dilution from new share grants. |
| Revolving Credit Facility Amendment | The Second Amendment to the 2022 Revolving Credit Facility increases the maximum permitted ratio of Consolidated Net Debt to Consolidated EBITDA through December 31, 2026. It also reduces general debt and liens baskets and limits restricted payments for equity interest redemptions during this period. | 2025-05-23 | This amendment provides the company with greater financial flexibility by easing leverage covenants, which could be crucial during periods of lower earnings. However, it also signals potential financial stress and restricts the company's ability to repurchase shares, impacting shareholder returns. |
Legal Proceedings
- On February 6, 2025, the Louisiana Supreme Court affirmed a jury verdict and district court judgment in Huntsman's favor in a long-running court battle against Praxair/Linde. Huntsman received a final award of approximately $66 million, including $23.5 million in mandatory pre-judgment and post-judgment interest, and recognized income of approximately $33 million, net of legal fees, during the first quarter of 2025. The company expects to pay cash taxes of approximately $8 million related to this matter in future years.
- The company is a party to various other proceedings instituted by private plaintiffs, governmental authorities, and others arising under applicable laws, including environmental and products liability laws. Management does not believe the outcome of these matters will have a material effect on financial condition, results of operations, or liquidity.
Related Party Transactions
- Related party sales amounted to $25 million for the three months ended June 30, 2025, and $61 million for the six months ended June 30, 2025, compared to $36 million and $70 million respectively in the prior year periods.
- Huntsman International declared and paid distributions to Huntsman Corporation in the form of certain affiliate accounts receivable during 2025 and 2024.
- The company holds a 49% interest in a PO/MTBE joint venture in China, which experienced an increase in losses, impacting equity in loss of investment in unconsolidated affiliates.
Stakeholder Impact
- Shareholders: Experienced a significant net loss and decline in earnings per share. The limitation on share repurchases due to the credit facility amendment may reduce potential returns, although dividends of $0.25 per share were maintained.
- Employees: Impacted by ongoing restructuring programs, including workforce reductions and facility closures (e.g., Moers, Germany facility), aimed at realigning cost structures.
- Customers: Lower average selling prices across segments may benefit customers, but reduced sales volumes suggest weaker demand or competitive pressures.
- Creditors: Increased total debt and the amendment to the revolving credit facility's leverage ratio indicate a higher risk profile, though the company states it is in compliance with covenants.
- Suppliers: The new supplier finance program allows certain vendors to sell receivables to a financial institution, potentially improving their liquidity, while Huntsman pays the financial institution on original terms.
Next Steps
- Continue to implement restructuring programs in the Polyurethanes and Advanced Materials segments, with expected further expenses through 2027.
- Fund capital expenditures of $180 million to $190 million during 2025.
- Make additional contributions of approximately $19 million to pension and other postretirement benefit plans during the remainder of 2025.
- Evaluate the impact of the One Big Beautiful Bill Act (OBBBA) tax reform legislation, though not expected to be material.
- Renew, repay, or extend the majority of short-term debt facilities in the next twelve months.
- Utilize cash held by foreign subsidiaries to fund local operations, with some amounts expected to be repatriated.
Key Dates
| Date | Description |
|---|---|
| 2021-10-26 | Huntsman's Board of Directors approved a new $1 billion share repurchase program. |
| 2022-03-25 | Huntsman's Board of Directors increased the share repurchase program authorization from $1 billion to $2 billion. |
| 2022-05-20 | Huntsman International entered into a $1.2 billion senior unsecured revolving credit facility (2022 Revolving Credit Facility). |
| 2022-10-01 | Beginning of a restructuring program to realign cost structure in Europe and optimize global managed services. |
| 2023-02-28 | Completed the sale of the Textile Effects Business to Archroma. |
| 2024-01-01 | Beginning of a restructuring program in the Advanced Materials segment to optimize manufacturing processes and cost structure in the U.S. |
| 2024-01-31 | Completed the planned separation and acquisition of assets of Shanghai Lianheng Isocyanate Company Ltd. (SLIC) joint venture. |
| 2024-03-31 | End of the three months period for 2024 financial comparison. |
| 2024-06-30 | End of the six months period for 2024 financial comparison. |
| 2024-10-01 | Beginning of a restructuring program in the Polyurethanes segment to reduce organizational structure costs. |
| 2024-12-31 | End of the fiscal year 2024 and balance sheet comparison date. |
| 2025-01-01 | Adoption of FASB ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (disclosures effective after December 15, 2025). |
| 2025-01-01 | Initiation of a supplier finance program. |
| 2025-02-06 | Louisiana Supreme Court affirmed jury verdict in favor of Huntsman in the Praxair/Linde litigation. |
| 2025-03-28 | Satisfied and discharged obligations under the 4.25% senior notes due April 2025. |
| 2025-04-01 | Maturity date of 4.25% senior notes due April 2025. |
| 2025-04-30 | Stockholders approved the new Huntsman Corporation 2025 Stock Incentive Plan. |
| 2025-05-23 | Huntsman International entered into a Second Amendment to the 2022 Revolving Credit Facility. |
| 2025-06-30 | End of the quarterly period covered by this report. |
| 2025-07-04 | U.S. enacted tax reform legislation through the One Big Beautiful Bill Act (OBBBA). |
| 2027-01-31 | Maturity date for the U.S. A/R Program. |
| 2027-05-01 | Maturity date for the 2022 Revolving Credit Facility. |
| 2027-07-31 | Maturity date for the EU A/R Program. |
| 2029-05-01 | Maturity date for 4.50% Senior Notes. |
| 2031-06-01 | Maturity date for 2.95% Senior Notes. |
| 2034-10-01 | Maturity date for 5.70% Senior Notes. |
Recommendation
sellThe filing reveals a substantial deterioration in Huntsman's financial performance, with significant net losses, declining revenues, gross profit, operating income, and adjusted EBITDA across all segments. While there are some positive cash flow improvements and a one-time legal settlement gain, these are overshadowed by the broad-based decline in core business profitability and substantial restructuring charges. The amendment to the credit facility to increase the maximum permitted leverage ratio, coupled with increased debt, signals underlying financial pressure. This overall negative trend in operational performance and increased financial leverage suggests a challenging outlook, warranting a 'sell' recommendation for a seasoned investor.
Keywords
Chemicals, Specialty Chemicals, Polyurethanes, Performance Products, Advanced Materials, MDI, Restructuring, SEC Filing, 10-Q, Financial Results, Debt, EBITDA, Net Loss, Share Repurchase, Environmental Liabilities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.